![](/img/cover-not-exists.png)
Inferior outcomes in immunocompromised Merkel cell carcinoma patients: Can they be overcome by the use of PD1/PDL1 inhibitors?
Dasanu, Constantin A, Del Rosario, Michael, Codreanu, Ion, Hyams, David M, Plaxe, Steven CLanguage:
english
Journal:
Journal of Oncology Pharmacy Practice
DOI:
10.1177/1078155218785002
Date:
June, 2018
File:
PDF, 106 KB
english, 2018